Custom Lucite commemorative recognizing legal advisory work done for a real estate client. The Texas-based commercial law firm Munsch Hardt represented its client, Newcrestimage, in an acquisition encompassing 106 hotel properties in 19 states. (22ALJ444)
Crystal commemorative marking a licensing and commercialization agreement between Corbus Pharmaceuticals and CSPC Pharmaceutical Group. The agreement centers on a potential treatment for tumors associated with lung, breast, and prostate cancers. (23AZH089)
Crystal deal toy commemorating the acquisition of oil and gas assets in the Eagle Ford shale in South Texas. (23AJH046)
Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Golf-themed crystal tombstone celebrating an agreement to end antitrust litigation between LIV Golf and the PGA. The agreement coincided with a merger announcement between the two parties. (23AZH136)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)
Lucite deal tombstone with bottle on weight scale. The tombstone commemorates KKR’s acquisition of Industrial Physics, which manufactures testing and inspection equipment for the plastics, coatings, materials etc. used by manufacturers and laboratories in a number of sectors. (23AKL351)
